Back to Search
Start Over
Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patients From an International Registry
- Source :
- Gastroenterology, Vol. 162, no. 1, p. 316-319.e5 (2022)
- Publication Year :
- 2022
- Subjects :
- 2019-20 coronavirus outbreak
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
MEDLINE
Inflammatory bowel disease
Severity of Illness Index
Adrenal Cortex Hormones
Internal medicine
medicine
Humans
Registries
Mesalamine
Hepatology
business.industry
SARS-CoV-2
Tumor Necrosis Factor-alpha
Gastroenterology
COVID-19
Odds ratio
medicine.disease
Inflammatory Bowel Diseases
Confidence interval
Sulfasalazine
Tumor necrosis factor alpha
business
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Gastroenterology, Vol. 162, no. 1, p. 316-319.e5 (2022)
- Accession number :
- edsair.doi.dedup.....5a5daf6d377cab6124b80f877077db36